Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma

Ocul Immunol Inflamm. 2021 Apr 3;29(3):507-520. doi: 10.1080/09273948.2021.1878233. Epub 2021 May 19.

Abstract

Purpose: To provide recommendations for diagnosis of vitreoretinal lymphoma (VRL).

Methods: Literature was reviewed for reports supporting the diagnosis of VRL. A questionnaire (Delphi 1 round) was distributed to 28 participants. In the second round (Delphi 2), items of the questionnaire not reaching consensus (75% agreement) were discussed to finalize the recommendations.

Results: Presenting symptoms include floaters and painless loss of vision, vitreous cells organized into sheets or clumps. Retinal lesions are usually multifocal creamy/white in the outer retina. Other findings include retinal lesions with "leopard-skin" appearance and retinal pigment epithelium atrophy. Severe vitreous infiltration without macular edema is the most likely presentation. Diagnostic vitrectomy should be performed. Systemic corticosteroid should be discontinued at least 2 weeks before surgery. An interleukin (IL)-10:IL-6 ratio > 1, positive mutation for the myeloid differentiation primary response 88 gene and monoclonality are indicators of VRL. Multi-modal imaging (optical coherence tomography, fundus autofluorescence) are recommended.

Conclusions: A consensus meeting allowed the establishment of recommendations important for the diagnosis of VRL.

Keywords: Vitreoretinal lymphoma; consensus recommendations; diagnosis.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Biomarkers, Tumor / metabolism
  • DNA Mutational Analysis
  • Delphi Technique
  • Humans
  • Interleukin-10 / metabolism
  • Interleukin-6 / metabolism
  • Intraocular Lymphoma / diagnosis*
  • Intraocular Lymphoma / genetics
  • Intraocular Lymphoma / metabolism
  • Lymphoma, Large B-Cell, Diffuse / diagnosis*
  • Lymphoma, Large B-Cell, Diffuse / genetics
  • Lymphoma, Large B-Cell, Diffuse / metabolism
  • Mutation, Missense
  • Myeloid Differentiation Factor 88 / genetics
  • Retinal Neoplasms / diagnosis*
  • Retinal Neoplasms / genetics
  • Retinal Neoplasms / metabolism
  • Retrospective Studies
  • Surveys and Questionnaires
  • Vitreous Body / metabolism
  • Vitreous Body / pathology*

Substances

  • Biomarkers, Tumor
  • IL10 protein, human
  • IL6 protein, human
  • Interleukin-6
  • MYD88 protein, human
  • Myeloid Differentiation Factor 88
  • Interleukin-10